Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A > G mutation in the mitochondrial tRNA Lys .
Mariantonietta CapristoValentina Del DottoConcetta Valentina TropeanoClaudio FioriniLeonardo CaporaliChiara La MorgiaMaria Lucia ValentinoMonica MontopoliValerio CarelliAlessandra MarescaPublished in: Molecular medicine (Cambridge, Mass.) (2022)
Overall, our results point to rapamycin-based therapy as a promising therapeutic option for MERRF.